ACADIA PHARMACEUTICALS INC — Director's Dealing 2016

Jun 9, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2016-06-07

Reporting Person: GRAY MARY ANN (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-07	Common Stock	M	6637	$9.04	Acquired	139476	Direct
2016-06-07	Common Stock	M	10000	$9.04	Acquired	149476	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-07	Stock option (right to buy)	$9.04	M	6637	Disposed	2016-06-12	Common Stock (6637)	Direct
2016-06-07	Stock option (right to buy)	$9.04	M	10000	Disposed	2016-06-12	Common Stock (10000)	Direct

Footnotes

F1: 25% of the shares subject to the Stock Option vested and became exercisable at the end of each 3-month period following the date of grant of June 13, 2006.